Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 15;376(6590):276-283.
doi: 10.1126/science.abn8382. Epub 2022 Apr 14.

Allylic C-H amination cross-coupling furnishes tertiary amines by electrophilic metal catalysis

Affiliations

Allylic C-H amination cross-coupling furnishes tertiary amines by electrophilic metal catalysis

Siraj Z Ali et al. Science. .

Abstract

Intermolecular cross-coupling of terminal olefins with secondary amines to form complex tertiary amines-a common motif in pharmaceuticals-remains a major challenge in chemical synthesis. Basic amine nucleophiles in nondirected, electrophilic metal-catalyzed aminations tend to bind to and thereby inhibit metal catalysts. We reasoned that an autoregulatory mechanism coupling the release of amine nucleophiles with catalyst turnover could enable functionalization without inhibiting metal-mediated heterolytic carbon-hydrogen cleavage. Here, we report a palladium(II)-catalyzed allylic carbon-hydrogen amination cross-coupling using this strategy, featuring 48 cyclic and acyclic secondary amines (10 pharmaceutically relevant cores) and 34 terminal olefins (bearing electrophilic functionality) to furnish 81 tertiary allylic amines, including 12 drug compounds and 10 complex drug derivatives, with excellent regio- and stereoselectivity (>20:1 linear:branched, >20:1 E:Z).

PubMed Disclaimer

Conflict of interest statement

Competing interests: The University of Illinois has a patent (US 10,266,503 B1) on sulfoxide-oxazoline ligands for Pd(II)-catalyzed allylic C–H functionalizations.

Figures

Fig. 1.
Fig. 1.. Reaction design and development.
(A) Merging the benefits of classic aminations (cyclic secondary amines) and C–H aminations (unactivated olefins) (middle) inspired the development of a fragment-coupling C–H amination to furnish complex tertiary amines (this work; bottom-middle). The challenges associated with basic amines in electrophilic metal-mediated catalysis include undesired Pd(II)-coordination that competes with C–H cleavage (bottom left). Our strategy uses catalyst turnover to regulate generation of secondary amine nucleophiles (bottom right). (B) Reaction development and optimization studies using secondary amine-BF3 complexes. All reactions were run on a 0.2-mmol scale open to air and moisture. All aminations proceeded in >20:1 linear:branched (L:B) and >20:1 E:Z selectivity, and free tertiary amines were isolated by means of a basic workup followed by column chromatography. Isolated yields are the average of two experiments. *Dibutyl phosphate. †The amine-BF3 was complexed in the reaction vial without purification and was then subjected to AACC catalysis (supplementary materials). ‡Yield was determined by crude 1H NMR analysis using benzotrifluoride as an internal standard.
Fig. 2.
Fig. 2.. AACC reaction scope.
(A) Aliphatic cyclic and acyclic amine scope, including the top five aliphatic tertiary amines found in medicinal chemistry (B) Terminal olefin scope. All reactions were run under ambient conditions. Unless otherwise indicated, all reactions were run on a 0.2-mmol scale using amine-BF3 (1 equivalent), olefin (1 equivalent), Pd(OAc)2 (10 mol %), (±)-MeO-SOX (10 mol %), 2,5-dimethyl-1,4-benzoquinone (2,5-DMBQ) (1.1 equivalents), and dbp in solvent (1 M) at 45 °C for 48 hours, followed by basic workup. All amination products were formed in >20:1 L:B and >20:1 E/Z selectivity, and isolated yields of the free tertiary amine products are the average of three experiments. *25% dbp in dioxane. †50% dbp in dioxane. ‡25% dbp in toluene (in some cases, toluene diminishes diene by-product formation). §50% dbp in toluene. ¶5% dbp in dioxane. #0.5 equivalents of amine-BF3. **0.4-mmol scale. ††5 mol % (±)-MeO-SOX·Pd(OAc)2. ‡‡0.167 M. §§0.4 M. ¶¶12 hours. ##24 hours. ***72 hours. †††Average of two experiments.
Fig. 3.
Fig. 3.. Synthesis of complex tertiary aliphatic amine drugs and drug derivatives.
(A and B) All reactions were run under ambient conditions. Unless otherwise indicated all reactions were run on a 0.2-mmol scale using amine-BF3 (1 equivalent), olefin (1 equivalent), Pd(OAc)2 (10 mol %), (±)-MeO-SOX (10 mol %), 2,5-DMBQ (1.1 equivalents), and dbp in solvent (1 M) at 45 °C for 48 hours, followed by basic workup. All amination products were formed in >20:1 L:B and >20:1 E/Z selectivity, and isolated yields of the free tertiary amine products are the average of three experiments. *25% dbp in dioxane. †50% dbp in dioxane. ‡25% dbp in toluene. §50% dbp in toluene. ¶50% dbp in methyl tert-butyl ether. #50% dbp in benzene. **5% dbp in dioxane. ††5 mol % (±)-MeO-SOX·Pd(OAc)2. ‡‡24 hours. §§72 hours. ¶¶Average of two experiments.
Fig. 4.
Fig. 4.. Mechanistic studies and proposed mechanism.
(A) Reaction profile monitored by quantitative 1H NMR analysis using benzotrifluoride as an internal standard. All time points (excluding t = 0 h and 48 hours) are the average of three experiments, with error bars indicating one standard deviation. The identity of 1·HBF4 was confirmed by matching its spectra to authentic material; however, we cannot exclude that other counterions (X) may be present. (B) Experiments to investigate the formation of free secondary amine nucleophile and the role of free tertiary amine in proton transfer as well as experiments to investigate reactivity at 5 mol % catalyst loading (cat. loading). See supplementary materials for details. *Yield was determined by crude 1H NMR analysis using mesitylene as an internal standard. (C) Proposed mechanism for AACC. 2,5-DMHQ, 2,5-dimethylhydroquinone.

References

    1. Roughley SD, Jordan AM, The medicinal chemists’s toolbox: an analysis of reactions used in pursuit of drug candidates. J. Med. Chem 54, 3451–3479 (2011). doi: 10.1021/jm200187y - DOI - PubMed
    1. Trowbridge A, Walton SM, Gaunt MJ, New strategies for the transition-metal catalyzed synthesis of aliphatic amines. Chem. Rev 120, 2613–2692 (2020). doi: 10.1021/acs.chemrev.9b00462 - DOI - PubMed
    1. Vitaku E, Smith DT, Njardarson JT, Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem 57, 10257–10274 (2014). doi: 10.1021/jm501100b - DOI - PubMed
    1. Wu Y-J, “Heterocycles and Medicine: A Survey of the Heterocyclic Drugs Approved by the U.S. FDA from 2000 to Present” in Progress in Heterocyclic Chemistry, Gribble GW, Joule JA, Eds. (Elsevier, 2012), vol. 24, chap. 1., pp. 1–53.
    1. Podyacheva E, Afanasyev OI, Tsygankov AA, Makarova M, Chusov D, Hitchhiker’s guide to reductive amination. Synthesis 51, 2667–2677 (2019). doi: 10.1055/s-0037-1611788 - DOI

Publication types